LONDON | Mon Oct 25, 2010 6:34am EDT
Recent research has identified the relatively high price of cervical cancer vaccines and low understanding of their benefits as key reasons why most young Canadian women have yet to be immunised, the British drugmaker said on Monday.
The new list price for Cervarix is C$90 ($87.63) per dose, down from C$134.95 previously. Three doses of the vaccine are recommended for protection.
Both Cervarix and Merck & Co’s (MRK.N) rival vaccine Gardasil protect against infection with the sexually transmitted human papillomavirus, which can cause cervical cancer. (Reporting by Ben Hirschler, editing by Kate Kelland)
Somebody is not buying something….
Never doubt what a small group of committed people can do in exposing the truth about the HPV vaccines.